These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9493443)

  • 1. [Expression of CD44 standard and CD44 variant 6 in human lung cancer].
    Ochiai S; Nakanishi Y; Mizuno K; Hashimoto S; Inutsuka S; Kawasaki M; Yatsunami J; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1179-85. PubMed ID: 9493443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis?
    Fasano M; Sabatini MT; Wieczorek R; Sidhu G; Goswami S; Jagirdar J
    Cancer; 1997 Jul; 80(1):34-41. PubMed ID: 9210706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance].
    Chai LX; Sun KL; Guo LP; Zhang HT; Lu SX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):685-8. PubMed ID: 18246799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of CD44 variant exon 6 in lung cancers].
    Wang FL; Wei LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):401-2. PubMed ID: 12940087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma.
    Ishida T
    Surg Today; 2000; 30(1):28-32. PubMed ID: 10648079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.
    Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M
    Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
    Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
    J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression of monoclonal antibody KM-93 reactive antigen in human lung carcinoma--an immunohistochemical evaluation].
    Sasaki K; Matsumura K; Ogino T; Tsuji T; Shinozaki F; Takahashi M
    Gan No Rinsho; 1988 Jul; 34(8):965-8. PubMed ID: 2457119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
    Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
    Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
    Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
    Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.